{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "SARS-CoV-2", "TCM", "herbs", "phytocompounds", "plant-derived compounds"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38281731", "DateCompleted": {"Year": "2024", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "14"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1002/ptr.8105"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "28"}], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "38", "Issue": "3", "PubDate": {"Year": "2024", "Month": "Mar"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Plant-derived compounds as potential leads for new drug development targeting COVID-19.", "Pagination": {"StartPage": "1522", "EndPage": "1554", "MedlinePgn": "1522-1554"}, "Abstract": {"AbstractText": ["COVID-19, which was first identified in 2019 in Wuhan, China, is a respiratory illness caused by a virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Although some patients infected with COVID-19 can remain asymptomatic, most experience a range of symptoms that can be mild to severe. Common symptoms include fever, cough, shortness of breath, fatigue, loss of taste or smell and muscle aches. In severe cases, complications can arise including pneumonia, acute respiratory distress syndrome, organ failure and even death, particularly in older adults or individuals with underlying health conditions. Treatments for COVID-19 include remdesivir, which has been authorised for emergency use in some countries, and dexamethasone, a corticosteroid used to reduce inflammation in severe cases. Biological drugs including monoclonal antibodies, such as casirivimab and imdevimab, have also been authorised for emergency use in certain situations. While these treatments have improved the outcome for many patients, there is still an urgent need for new treatments. Medicinal plants have long served as a valuable source of new drug leads and may serve as a valuable resource in the development of COVID-19 treatments due to their broad-spectrum antiviral activity. To date, various medicinal plant extracts have been studied for their cellular and molecular interactions, with some demonstrating anti-SARS-CoV-2 activity in vitro. This review explores the evaluation and potential therapeutic applications of these plants against SARS-CoV-2. This review summarises the latest evidence on the activity of different plant extracts and their isolated bioactive compounds against SARS-CoV-2, with a focus on the application of plant-derived compounds in animal models and in human studies."], "CopyrightInformation": "\u00a9 2024 The Authors. Phytotherapy Research published by John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0003-1689-1787"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medical Sciences, School of Pharmacy, Newcastle University, Newcastle-Upon-Tyne, UK."}, {"Identifier": [], "Affiliation": "Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle-Upon-Tyne, UK."}], "LastName": "Liu", "ForeName": "Lingxiu", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Natural and Environmental Sciences, Faculty of Science, Agriculture and Engineering, Newcastle University, Newcastle-Upon-Tyne, UK."}], "LastName": "Kapralov", "ForeName": "Maxim", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medical Sciences, School of Pharmacy, Newcastle University, Newcastle-Upon-Tyne, UK."}, {"Identifier": [], "Affiliation": "Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle-Upon-Tyne, UK."}], "LastName": "Ashton", "ForeName": "Mark", "Initials": "M"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "COVID-19"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Phytochemicals"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Abdallah, H. M., El-Halawany, A. M., Sirwi, A., El-Araby, A. M., Mohamed, G. A., Ibrahim, S. R., Koshak, A. E., Asfour, H. Z., Awan, Z. A., & Elfaky, A. (2021). Repurposing of some natural product isolates as SARS-CoV-2 Main protease inhibitors via in vitro cell free and cell-based antiviral assessments and molecular modeling approaches. Pharmaceuticals, 14(3), 213."}, {"Citation": "Acarli, A. N. \u00d6., Samanci, B., Ekizo\u011flu, E., \u00c7akar, A., \u015eirin, N. G., G\u00fcnd\u00fcz, T., Parman, Y., & Baykan, B. (2020). Coronavirus disease 2019 (COVID-19) from the point of view of neurologists: Observation of neurological findings and symptoms during the combat against a pandemic. Archives of Neuropsychiatry, 57(2), 154-159."}, {"Citation": "Ahmad, S., Zahiruddin, S., Parveen, B., Basist, P., Parveen, A., Parveen, R., & Ahmad, M. (2021). Indian medicinal plants and formulations and their potential against COVID-19-preclinical and clinical research. Frontiers in Pharmacology, 11, 2470."}, {"Citation": "Alhadrami, H. A., Burgio, G., Thissera, B., Orfali, R., Jiffri, S. E., Yaseen, M., Sayed, A. M., & Rateb, M. E. (2022). Neoechinulin A as a promising SARS-CoV-2\u2009M-pro inhibitor: In vitro and in Silico study showing the ability of simulations in discerning active from inactive enzyme inhibitors. Marine Drugs, 20(3), 163."}, {"Citation": "Alhadrami, H. A., Sayed, A. M., Sharif, A. M., Azhar, E. I., & Rateb, M. E. (2021). Olive-derived triterpenes suppress SARS COV-2 main protease: A promising scaffold for future therapeutics. Molecules, 26(9), 2654."}, {"Citation": "Al-Karmalawy, A. A., Farid, M. M., Mostafa, A., Ragheb, A. Y., Mahmoud, S. H., Shehata, M., Abo Shama, N. M., GabAllah, M., Mostafa-Hedeab, G., & Marzouk, M. M. (2021). Naturally available flavonoid Aglycones as potential antiviral drug candidates against SARS-CoV-2. Molecules, 26(21), 1317."}, {"Citation": "Amgalan, A., & Othman, M. (2020). Hemostatic laboratory derangements in COVID-19 with a focus on platelet count. Platelets, 31(6), 740-745."}, {"Citation": "Anil, S. M., Shalev, N., Vinayaka, A. C., Nadarajan, S., Namdar, D., Belausov, E., Shoval, I., Mani, K. A., Mechrez, G., & Koltai, H. (2021). Cannabis compounds exhibit anti-inflammatory activity in vitro in COVID-19-related inflammation in lung epithelial cells and pro-inflammatory activity in macrophages. Scientific Reports, 11(1), 1462."}, {"Citation": "Antunes, L. M. G., Darin, J., & Bianchi, M. D. P. (2001). Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacological Research, 43(2), 145-150."}, {"Citation": "Ao, Z., Chan, M., Ouyang, M. J., Olukitibi, T. A., Mahmoudi, M., Kobasa, D., & Yao, X. (2021). Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry. PloS One, 16(6), e0251649."}, {"Citation": "Azkur, A. K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Br\u00fcggen, M. C., O'Mahony, L., Gao, Y., Nadeau, K., & Akdis, C. A. (2020). Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy, 75(7), 1564-1581."}, {"Citation": "Balkrishna, A., Haldar, S., Singh, H., Roy, P., & Varshney, A. (2021). Coronil, a tri-herbal formulation, attenuates spike-protein-mediated SARS-CoV-2 viral entry into human alveolar epithelial cells and pro-inflammatory cytokines production by inhibiting spike protein-ACE-2 interaction. Journal of Inflammation Research, 14, 869-884."}, {"Citation": "Balkrishna, A., Pokhrel, S., Singh, H., Joshi, M., Mulay, V. P., Haldar, S., & Varshney, A. (2021). Withanone from Withania somnifera attenuates SARS-CoV-2 RBD and host ACE2 interactions to rescue spike protein induced pathologies in humanized zebrafish model. Drug Design Development and Therapy, 15, 1111-1133."}, {"Citation": "Balkrishna, A., Verma, S., Sharma, P., Tomer, M., Srivastava, J., & Varshney, A. (2021). Comprehensive and rapid quality evaluation method for the Ayurvedic medicine Divya-Swasari-Vati using two analytical techniques: UPLC/QToF MS and HPLC-DAD. Pharmaceuticals, 14(4), 297."}, {"Citation": "Balkrishna, A., Verma, S., Solleti, S. K., Khandrika, L., & Varshney, A. (2020). Calcio-herbal medicine Divya-Swasari-Vati ameliorates SARS-CoV-2 spike protein-induced pathological features and inflammation in humanized zebrafish model by moderating IL-6 and TNF-\u03b1 cytokines. Journal of Inflammation Research, 13, 1219-1243."}, {"Citation": "Bemtgen, X., Zotzmann, V., Benk, C., Rilinger, J., Steiner, K., Asmussen, A., Bode, C., Wengenmayer, T., Maier, S., & Staudacher, D. L. (2021). Thrombotic circuit complications during Venovenous extracorporeal membrane oxygenation in COVID-19. Journal of Thrombosis and Thrombolysis, 51, 301-307."}, {"Citation": "Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020). Severe covid-19. New England Journal of Medicine, 383(25), 2451-2460."}, {"Citation": "Bhat, S. S., Pradeep, S., Patil, S. S., Flores-Holgu\u00edn, N., Glossman-Mitnik, D., Frau, J., Sommano, S. R., Ali, N., Mohany, M., Shivamallu, C., & Prasad, S. K. (2023). Preliminary evaluation of Lablab purpureus phytochemicals for anti-BoHV-1 activity using in vitro and in Silico approaches. ACS. Omega, 8(25), 22684-22697."}, {"Citation": "Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., & Guo, Y. (2020). COVID-19 and thrombotic or thromboembolic disease: Implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. Journal of the American College of Cardiology, 75(23), 2950-2973."}, {"Citation": "Bousquet, J., Le Moing, V., Blain, H., Czarlewski, W., Zuberbier, T., de la Torre, R., Lozano, N. P., Reynes, J., Bedbrook, A., & Cristol, J.-P. (2021). Efficacy of broccoli and glucoraphanin in COVID-19: From hypothesis to proof-of-concept with three experimental clinical cases. World Allergy Organization Journal, 14(1), 100498."}, {"Citation": "Buhner, S. H. (2020). Plant-based interventions for coronavirus (SARS-CoV-2). Available at: https://www.americanherbalistsguild.com/sites/americanherbalistsguild.com/files/coronavirus-1.pdf. [Accessed: 26th September 2023]."}, {"Citation": "Cao, J. Y., Liu, Y., Zhou, M. M., Dong, S. Q., Hou, Y. X., Jia, X. Y., Lan, X. H., Zhang, Y. L., Guo, J., Xiao, G. F., & Wang, W. (2022). Screening of botanical drugs against SARS-CoV-2 entry reveals novel therapeutic agents to treat COVID-19. Viruses-Basel, 14(2), 353."}, {"Citation": "Cardona, G. C., P\u00e1jaro, L. D. Q., Marzola, I. D. Q., Villegas, Y. R., & Salazar, L. R. M. (2020). Neurotropism of SARS-CoV 2: Mechanisms and manifestations. Journal of the Neurological Sciences, 412, 116824."}, {"Citation": "Cecchini, R., & Cecchini, A. L. (2020). SARS-CoV-2 infection pathogenesis is related to oxidative stress as a response to aggression. Medical Hypotheses, 143, 110102."}, {"Citation": "Chauhan, M., Bhardwaj, V. K., Kumar, A., Kumar, V., Kumar, P., Enayathullah, M. G., Thomas, J., George, J., Kumar, B. K., Purohit, R., & Kumar, A. (2022). Theaflavin 3-gallate inhibits the main protease (Mpro) of SARS-CoV-2 and reduces its count in vitro. Scientific Reports, 12(1), 13146."}, {"Citation": "Chen, B., Yu, X., Zhang, L., Huang, W., Lyu, H., Xu, Y., Shen, J., Yuan, W., Fang, M., & Li, M. (2023). Clinical efficacy of Jingyin granules, a Chinese patent medicine, in treating patients infected with coronavirus disease 2019. Phytomedicine, 108, 154496."}, {"Citation": "Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., & Wei, Y. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507-513."}, {"Citation": "Chen, R., Sang, L., Jiang, M., Yang, Z., Jia, N., Fu, W., Xie, J., Guan, W., Liang, W., & Ni, Z. (2020). Longitudinal hematologic and immunologic variations associated with the progression of COVID-19 patients in China. Journal of Allergy and Clinical Immunology, 146(1), 89-100."}, {"Citation": "Chen, Z. N., Cui, Q. H., Cooper, L., Zhang, P., Lee, H., Chen, Z. Y., Wang, Y. Y., Liu, X. Y., Rong, L. J., & Du, R. K. (2021). Ginkgolic acid and anacardic acid are specific covalent inhibitors of SARS-CoV-2 cysteine proteases. Cell and Bioscience, 11(1), 1-8."}, {"Citation": "Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., Li, J., Yao, Y., Ge, S., & Xu, G. (2020). KIdney disease is associated with in-hospital death of patients with COVID-19. Kidney International, 97(5), 829-838."}, {"Citation": "Chin, Y. F., Tang, W. F., Chang, Y. H., Chang, T. Y., Lin, W. C., Lin, C. Y., Yang, C. M., Wu, H. L., Liu, P. C., Sun, J. R., Hsu, S. C., Lee, C. Y., Lu, H. Y., Chang, J. Y., Jheng, J. R., Chen, C. C., Huang, C. H., Chiu, C. H., Hung, Y. J., \u2026 Horng, J. T. (2022). Orally delivered perilla (Perilla frutescens) leaf extract effectively inhibits SARS-CoV-2 infection in a Syrian hamster model. Journal of Food and Drug Analysis, 30(2), 252-270."}, {"Citation": "Chiou, W. C., Chen, J. C., Chen, Y. T., Yang, J. M., Hwang, L. H., Lyu, Y. S., Yang, H. Y., & Huang, C. (2022). The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease. Biochemical and Biophysical Research Communications, 591, 130-136."}, {"Citation": "Chitre, D., Nadkarni, S., Jagtap, N., Tulle, R., Gitte, A., Rahate, P., Chaskar, S., & Dey, D. (2022). Phase III randomized clinical trial of BV-4051, an Ayurvedic polyherbal formulation in moderate SARS-CoV-2 infections and its impact on inflammatory biomarkers. Phytotherapy Research, 37, 1232-1241."}, {"Citation": "Choonong, R., Ruangdachsuwan, S., Churod, T., Palabodeewat, S., Punyahathaikul, S., Juntarapornchai, S., Ketsuwan, K., Komaikul, J., Masrinoul, P., Kitisripanya, T., & Juengwatanatrakul, T. (2022). Evaluating the in vitro efficacy of quassinoids from Eurycoma longifolia and Eurycoma harmandiana against common cold human coronavirus OC43 and SARS-CoV-2 using in-cell enzyme-linked immunosorbent assay. Journal of Natural Products, 85(12), 2779-2788."}, {"Citation": "Danwang, C., Endomba, F. T., Nkeck, J. R., Wouna, D. L. A., Robert, A., & Noubiap, J. J. (2020). A meta-analysis of potential biomarkers associated with severity of coronavirus disease 2019 (COVID-19). Biomarker Research, 8(1), 1-13."}, {"Citation": "Della-Torre, E., Della-Torre, F., Kusanovic, M., Scotti, R., Ramirez, G. A., Dagna, L., & Tresoldi, M. (2020). Treating COVID-19 with colchicine in community healthcare setting. Clinical Immunology, 217, 108490."}, {"Citation": "Diniz, L. R. L., Elshabrawy, H. A., Souza, M. T. S., Duarte, A. B. S., Madhav, N., & de Sousa, D. P. (2022). Renoprotective effects of luteolin: Therapeutic potential for COVID-19-associated acute kidney injuries. Biomolecules, 12(11), 1544."}, {"Citation": "Diniz, L. R. L., Souza, M. T. D. S., Duarte, A. B. S., & Sousa, D. P. D. (2020). Mechanistic aspects and therapeutic potential of quercetin against COVID-19-associated acute kidney injury. Molecules, 25(23), 5772."}, {"Citation": "Du, A. S., Zheng, R., Disoma, C., Li, S. Q., Chen, Z. P., Li, S. J., Liu, P. J., Zhou, Y. Z., Shen, Y. L., Liu, S. X., Zhang, Y. X., Dong, Z. J., Yang, Q. L., Alsaadawe, M., Razzaq, A., Peng, Y. Y., Chen, X., Hu, L. Q., Peng, J., \u2026 Xia, Z. X. (2021). Epigallocatechin-3-gallate, an active ingredient of traditional Chinese medicines, inhibits the 3CLpro activity of SARS-CoV-2. International Journal of Biological Macromolecules, 176, 1-12."}, {"Citation": "Du, X., Xu, L., Ma, Y., Lu, S., Tang, K., Qiao, X., Liu, J., Wang, X., Peng, X., & Jiang, C. (2022). Herbal inhibitors of SARS-CoV-2 Mpro effectively ameliorate acute lung injury in mice. IUBMB Life, 74(6), 532-542."}, {"Citation": "El Alami, A., Fattah, A., & Chait, A. (2020). Medicinal plants used for the prevention purposes during the covid-19 pandemic in Morocco. Journal of Analytical Sciences and Applied Biotechnology, 2(1), 4-11."}, {"Citation": "El Gizawy, H. A., Boshra, S. A., Mostafa, A., Mahmoud, S. H., Ismail, M. I., Alsfouk, A. A., Taher, A. T., & Al-Karmalawy, A. A. (2021). Pimenta dioica (L.) Merr. Bioactive constituents exert anti-SARS-CoV-2 and anti-inflammatory activities: Molecular docking and dynamics, in vitro, and in vivo studies. Molecules, 26(19), 5844."}, {"Citation": "Elebeedy, D., Elkhatib, W. F., Kandeil, A., Ghanem, A., Kutkat, O., Alnajjar, R., Saleh, M. A., Abd El Maksoud, A. I., Badawy, I., & Al-Karmalawy, A. A. (2021). Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights. RSC Advances, 11(47), 29267-29286."}, {"Citation": "El-Hawary, S. S., Ali, T. F., El-Ela, S. O. A., Elwekeel, A., Abdelmohsen, U. R., & Owis, A. I. (2022). Secondary metabolites of Livistona decipiens as potential inhibitors of SARS-CoV-2. RSC Advances, 12(30), 19505-19511."}, {"Citation": "Enmozhi, S. K., Raja, K., Sebastine, I., & Joseph, J. (2021). Andrographolide as a potential inhibitor of SARS-CoV-2 main protease: An in silico approach. Journal of Biomolecular Structure and Dynamics, 39(9), 3092-3098."}, {"Citation": "Estevez-Cerda, S., Salda\u00f1a-Rodr\u00edguez, J., Alam-Gidi, A., Riojas-Garza, A., Rodarte-Shade, M., Velazco-de la Garza, J., Leyva-Alvizo, A., Gonzalez-Ruvalcaba, R., Martinez-Resendez, M., & de Elguea-Lizarraga, J. O. (2021). Complicaciones intestinales graves en pacientes SARS-CoV-2 recibiendo manejo protocolizado. Revista de Gastroenterolog\u00eda de M\u00e9xico, 86(4), 378-386."}, {"Citation": "European Medicine Agency. (2016). Assessment Report on Paeonia lactiflora Pallas, Radix (Paeoniae Radix Alba). EMA/HHMP/762954/2015 Committee on Herbal Medicinal Products (HMPC)."}, {"Citation": "Fakher, S., Peymani, P., Ghavami, S., & Mokarram, P. (2020). The role of autophagy in respiratory complications of COVID-19. Shiraz E-Medical Journal, 21(6), e102967."}, {"Citation": "Ferreira, J. (2023). New insights into SARS-CoV-2 brain infection and olfactory impairment in the hamster model. Lab Animal, 52(9), 201."}, {"Citation": "Fu, L., Wang, B., Yuan, T., Chen, X., Ao, Y., Fitzpatrick, T., Li, P., Zhou, Y., Lin, Y.-f., & Duan, Q. (2020). Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis. Journal of Infection, 80(6), 656-665."}, {"Citation": "Gandhi, R. T., Lynch, J. B., & Del Rio, C. (2020). Mild or moderate Covid-19. New England Journal of Medicine, 383(18), 1757-1766."}, {"Citation": "Gao, J. P., Ding, Y. Y., Wang, Y. J., Liang, P. D., Zhang, L. Y., & Liu, R. (2021). Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography. Phytotherapy Research, 35(6), 3194-3204."}, {"Citation": "Garg, V., Dhar, V. J., Sharma, A., & Dutt, R. (2012). Facts about standardization of herbal medicine: A review. Zhong xi Yi Jie He Xue Bao\u2009=\u2009Journal of Chinese Integrative Medicine, 10(10), 1077-1083."}, {"Citation": "Gasparello, J., D'Aversa, E., Papi, C., Gambari, L., Grigolo, B., Borgatti, M., Finotti, A., & Gambari, R. (2021). Sulforaphane inhibits the expression of interleukin-6 and interleukin-8 induced in bronchial epithelial IB3-1 cells by exposure to the SARS-CoV-2 spike protein. Phytomedicine, 87, 153583."}, {"Citation": "Godaert, L., Proye, E., Demoustier-Tampere, D., Coulibaly, P. S., Hequet, F., & Dram\u00e9, M. (2020). Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France. Journal of Infection, 81(1), e93-e94."}, {"Citation": "Gong, G., Guan, Y. Y., Zhang, Z. L., Rahman, K., Wang, S. J., Zhou, S., Luan, X., & Zhang, H. (2020). Isorhamnetin: A review of pharmacological effects. Biomedicine & Pharmacotherapy, 128, 110301."}, {"Citation": "Gonzalez-Maldonado, P., Alvarenga, N., Burgos-Edwards, A., Flores-Giubi, M. E., Barua, J. E., Romero-Rodriguez, M. C., Soto-Rifo, R., Valiente-Echeverria, F., Langjahr, P., Cantero-Gonzalez, G., & Sotelo, P. H. (2022). Screening of natural products inhibitors of SARS-CoV-2 entry. Molecules, 27(5), 1743."}, {"Citation": "Gowda, P., Patrick, S., Joshi, S. D., Kumawat, R. K., & Sen, E. (2021). Glycyrrhizin prevents SARS-CoV-2\u2009S1 and Orf3a induced high mobility group box 1 (HMGB1) release and inhibits viral replication. Cytokine, 142, 155496."}, {"Citation": "Guijarro-Real, C., Plazas, M., Rodr\u00edguez-Burruezo, A., Prohens, J., & Fita, A. (2021). Potential in vitro inhibition of selected plant extracts against SARS-CoV-2 chymotripsin-like protease (3CLPro) activity. Foods, 10(7), 1503."}, {"Citation": "Guo, T., Fan, Y., Chen, M., Wu, X., Zhang, L., He, T., Wang, H., Wan, J., Wang, X., & Lu, Z. (2020). Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiology, 5(7), 811-818."}, {"Citation": "Hariono, M., Hariyono, P., Dwiastuti, R., Setyani, W., Yusuf, M., Salin, N., & Wahab, H. (2021). Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies. Results in Chemistry, 3, 100195."}, {"Citation": "Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., & Mehrabi, M. (2021). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 39(8), 3025-3033."}, {"Citation": "Hu, B., Guo, H., Zhou, P., & Shi, Z. L. (2021). Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Microbiology, 19(3), 141-154."}, {"Citation": "Hu, G. M., Tai, Y. C., & Chen, C. M. (2023). Unraveling the evolutionary patterns and phylogenomics of coronaviruses: A consensus network approach. Journal of Medical Virology, 95(11), e29233."}, {"Citation": "Hu, K., Guan, W. J., Bi, Y., Zhang, W., Li, L., Zhang, B., Liu, Q., Song, Y., Li, X., Duan, Z., & Zheng, Q. (2021). Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: a multicenter, prospective, randomized controlled trial. Phytomedicine, 85, 153242."}, {"Citation": "Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., & Gu, X. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497-506."}, {"Citation": "Huang, G., Kovalic, A. J., & Graber, C. J. (2020). Prognostic value of leukocytosis and lymphopenia for coronavirus disease severity. Emerging Infectious Diseases, 26(8), 1839-1841."}, {"Citation": "Huang, K. P., Chen, C., Hao, J., Huang, J. Y., Wang, S. G., Liu, P. Q., & Huang, H. Q. (2015). Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-\u03b21 in rat glomerular messangial cells. Molecular and Cellular Endocrinology, 399, 178-189."}, {"Citation": "Huang, S. T., Chen, Y., Chang, W. C., Chen, H. F., Lai, H. C., Lin, Y. C., Wang, W. J., Wang, Y. C., Yang, C. S., Wang, S. C., & Hung, M. C. (2021). Scutellaria barbata D. Don inhibits the main proteases (Mpro and TMPRSS2) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Viruses, 13(5), 826."}, {"Citation": "Islam, A. R., Ferdousi, J., & Shahinozzaman, M. (2021). Previously published ethno-pharmacological reports reveal the potentiality of plants and plant-derived products used as traditional home remedies by Bangladeshi COVID-19 patients to combat SARS-CoV-2. Saudi Journal of Biological Sciences, 28(11), 6653-6673."}, {"Citation": "Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022). Mechanisms of SARS-CoV-2 entry into cells. Nature Reviews Molecular Cell Biology, 23(1), 3-20."}, {"Citation": "Jamshidnia, M., Sewell, R. D., & Rafieian-Kopaei, M. (2022). An update on promising agents against COVID-19: Secondary metabolites and mechanistic aspects. Current Pharmaceutical Design, 28(29), 2415-2425."}, {"Citation": "Jan, J.-T., Cheng, T.-J. R., Juang, Y.-P., Ma, H.-H., Wu, Y.-T., Yang, W.-B., Cheng, C.-W., Chen, X., Chou, T.-H., & Shie, J.-J. (2021). Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection. Proceedings of the National Academy of Sciences, 118(5), e2021579118."}, {"Citation": "Jang, M., Park, Y.-I., Cha, Y.-E., Park, R., Namkoong, S., Lee, J. I., & Park, J. (2020). Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV-2 3CL-protease in vitro. Evidence-Based Complementary and Alternative Medicine: eCAM, 2020, 5630838."}, {"Citation": "Jin, Y. H., Min, J. S., Jeon, S., Lee, J., Kim, S., Park, T., Park, D., Jang, M. S., Park, C. M., Song, J. H., Kim, H. R., & Kwon, S. (2021). Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. Phytomedicine, 86, 153440."}, {"Citation": "Jin, Z., Du, X., Xu, Y. et al. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582, 289-293. https://doi.org/10.1038/s41586-020-2223-y"}, {"Citation": "Jo, S., Kim, S., Kim, D. Y., Kim, M. S., & Shin, D. H. (2020). Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 1539-1544."}, {"Citation": "Karimi, M., Zarei, A., Soleymani, S., Jamalimoghadamsiahkali, S., Asadi, A., Shati, M., Jafari, M., Rezadoost, H., Kordafshar, G., & Naghizadeh, A. (2021). Efficacy of Persian medicine herbal formulations (capsules and decoction) compared to standard care in patients with COVID-19, a multicenter open-labeled, randomized, controlled clinical trial. Phytotherapy Research, 35(11), 6295-6309."}, {"Citation": "Kashyap, P., Bhardwaj, V. K., Chauhan, M., Chauhan, V., Kumar, A., Purohit, R., Kumar, A., & Kumar, S. (2022). A ricin-based peptide BRIP from Hordeum vulgare inhibits M-pro of SARS-CoV-2. Scientific Reports, 12(1), 12802."}, {"Citation": "Katritch, V., & Sadybekov, A.V., (2023). Computational approaches streamlining drug discovery. Nature, 616, 673-685. https://doi.org/10.1038/s41586-023-05905-z"}, {"Citation": "Kaushik, D., Bhandari, R., & Kuhad, A. (2021). TLR4 as a therapeutic target for respiratory and neurological complications of SARS-CoV-2. Expert Opinion on Therapeutic Targets, 25(6), 491-508."}, {"Citation": "Kesarwani, K., & Gupta, R. (2013). Bioavailability enhancers of herbal origin: An overview. Asian Pacific Journal of Tropical Biomedicine, 3(4), 253-266."}, {"Citation": "Khadka, D., Dhamala, M. K., Li, F., Aryal, P. C., Magar, P. R., Bhatta, S., Thakur, M. S., Basnet, A., Cui, D., & Shi, S. (2021). The use of medicinal plants to prevent COVID-19 in Nepal. Journal of Ethnobiology and Ethnomedicine, 17(1), 1-17."}, {"Citation": "Khan, A., Heng, W., Wang, Y., Qiu, J., Wei, X., Peng, S., Saleem, S., Khan, M., Ali, S. S., & Wei, D. Q. (2021). In silico and invitro evaluation of kaempferol as a potential inhibitor of the SARS-CoV-2 main protease (3CLpro). Phytotherapy Research, 35(6), 2841."}, {"Citation": "Khodadadi, H., Salles, \u00c9. L., Jarrahi, A., Chibane, F., Costigliola, V., Yu, J. C., Vaibhav, K., Hess, D. C., Dhandapani, K. M., & Baban, B. (2020). Cannabidiol modulates cytokine storm in acute respiratory distress syndrome induced by simulated viral infection using synthetic RNA. Cannabis and cannabinoid research, 5(3), 197-201."}, {"Citation": "Kiba, Y., Oyama, R., Misawa, S., Tanikawa, T., Kitamura, M., & Suzuki, R. (2021). Screening for inhibitory effects of crude drugs on Furin-like enzymatic activities. Journal of Natural Medicines, 75(4), 1080-1085."}, {"Citation": "Kumar Das, S., Dash, D. P., Panda, P. K., Sadana, S., & Kumar, R. M. R. (2023). \u2018The efficacy of a plant based formulation in the symptomatic Management of Mild COVID-19 cases: A double blind, randomized controlled trial. Archives of Clinical and Medical Case Reports, 7(1), 5-12."}, {"Citation": "Kunnumakkara, A. B., Hegde, M., Parama, D., Girisa, S., Kumar, A., Daimary, U. D., Garodia, P., Yenisetti, S. C., Oommen, O. V., & Aggarwal, B. B. (2023). Role of turmeric and curcumin in prevention and treatment of chronic diseases: Lessons learned from clinical trials. ACS Pharmacology and Translational Science, 6(4), 447-518."}, {"Citation": "Le, N. P. K., Herz, C., Gomes, J. V. D., F\u00f6rster, N., Antoniadou, K., Mittermeier-Kle\u00dfinger, V. K., Mewis, I., Dawid, C., Ulrichs, C., & Lamy, E. (2021). Comparative anti-inflammatory effects of Salix cortex extracts and acetylsalicylic acid in SARS-CoV-2 peptide and LPS-activated human in vitro systems. International journal of molecular sciences, 22(13), 6766."}, {"Citation": "Lechien, J. R., Chiesa-Estomba, C. M., Place, S., Van Laethem, Y., Cabaraux, P., Mat, Q., Huet, K., Plzak, J., Horoi, M., & Hans, S. (2020). Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. Journal of Internal Medicine, 288(3), 335-344."}, {"Citation": "Lei, F., Liu, Y. M., Zhou, F., Qin, J. J., Zhang, P., Zhu, L., Zhang, X. J., Cai, J., Lin, L., & Ouyang, S. (2020). Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology, 72(2), 389-398."}, {"Citation": "Leuenroth, S. J., Okuhara, D., Shotwell, J. D., Markowitz, G. S., Yu, Z. H., Somlo, S., & Crews, C. M. (2007). Triptolide is a traditional Chinese medicine-derived inhibitor of polycystic kidney disease. Proceedings of the National Academy of Sciences of the United States of America, 104(11), 4389-4394."}, {"Citation": "Li, J., Xu, D., Wang, L., Zhang, M., Zhang, G., Li, E., & He, S. (2021). Glycyrrhizic acid inhibits SARS-CoV-2 infection by blocking spike protein-mediated cell attachment. Molecules, 26(20), 6090."}, {"Citation": "Li, S., Xu, Y., Guo, W., Chen, F., Zhang, C., Tan, H. Y., Wang, N., & Feng, Y. (2020). The impacts of herbal medicines and natural products on regulating the hepatic lipid metabolism. Frontiers in Pharmacology, 11, 351."}, {"Citation": "Li, S., Ye, M., Chen, Y., Zhang, Y., Li, J., Liu, W., Li, H., & Peng, K. (2021). Screening of a small molecule compound library identifies Toosendanin as an inhibitor against bunyavirus and SARS-CoV-2. Frontiers in Pharmacology, 12, 735223."}, {"Citation": "Li, X., Gao, J., Li, M., Cui, H., Jiang, W., Tu, Z.-c., & Yuan, T. (2021). Aromatic cadinane sesquiterpenoids from the fruiting bodies of Phellinus pini block SARS-CoV-2 spike-ACE2 interaction. Journal of Natural Products, 84(8), 2385-2389."}, {"Citation": "Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., Shi, J., Zhou, M., Wu, B., & Yang, Z. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology, 146(1), 110-118."}, {"Citation": "Lin, S., Wang, X., Tang, R. W.-L., Lee, H. C., Chan, H. H., Choi, S. S., Dong, T. T.-X., Leung, K. W., Webb, S. E., & Miller, A. L. (2022). The extracts of Polygonum cuspidatum root and rhizome block the entry of SARS-CoV-2 wild-type and omicron pseudotyped viruses via inhibition of the S-protein and 3CL protease. Molecules, 27(12), 3806."}, {"Citation": "Lippi, G., Plebani, M., & Henry, B. M. (2020). Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis. Clinica Chimica Acta, 506, 145-148."}, {"Citation": "Liu, H., Ye, F., Sun, Q., Liang, H., Li, C., Li, S., Lu, R., Huang, B., Tan, W., & Lai, L. (2021). Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro. Journal of Enzyme Inhibition and Medicinal Chemistry, 36(1), 497-503."}, {"Citation": "Liu, J., Li, S., Liu, J., Liang, B., Wang, X., Wang, H., Li, W., Tong, Q., Yi, J., & Zhao, L. (2020). Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine, 55, 102763."}, {"Citation": "Liu, M., Gao, Y., Yuan, Y., Yang, K., Shi, S., Tian, J., & Zhang, J. (2021). Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: A systematic review and meta-analysis. Integrative Medicine Research, 10(1), 100644."}, {"Citation": "Liu, S.-Y., Wang, W., Ke, J.-P., Zhang, P., Chu, G.-X., & Bao, G.-H. (2022). Discovery of Camellia sinensis catechins as SARS-CoV-2 3CL protease inhibitors through molecular docking, intra and extra cellular assays. Phytomedicine, 96, 153853."}, {"Citation": "Liu, W. T., Zheng, W. K., Cheng, L. P., Li, M., Huang, J., Bao, S. Z., Xu, Q., & Ma, Z. C. (2022). Citrus fruits are rich in flavonoids for immunoregulation and potential targeting ACE2. Natural Products and Bioprospecting, 12(1), 1-10."}, {"Citation": "Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., & Bertuzzi, A. (2020). \u2018Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan. Italy\u2019, Thrombosis Research, 191, 9-14."}, {"Citation": "Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., & Dabrera, G. (2021). Effectiveness of COVID-19 vaccines against the B. 1.617. 2 (Delta) variant. New England Journal of Medicine, 385(7), 585-594."}, {"Citation": "Lu, X., Yujing, S., Jie, S., Friedemann, T., Zhenggang, T., Lu, Y., Yun, L., Lv, Y., Ronghua, Z., & Zihan, G. (2021). Shufeng Jiedu, a promising herbal therapy for moderate COVID-19: Antiviral and anti-inflammatory properties, pathways of bioactive compounds, and a clinical real-world pragmatic study. Phytomedicine, 85, 153390."}, {"Citation": "Magurano, F., Sucameli, M., Picone, P., Micucci, M., Baggieri, M., Marchi, A., Bucci, P., Gioacchini, S., Catinella, G., & Borgonovo, G. (2021). Antioxidant activity of citrus limonoids and investigation of their virucidal potential against SARS-CoV-2 in cellular models. Antioxidants, 10(11), 1794."}, {"Citation": "Mahdavi-Roshan, M., Salari, A., Mohammadyari, E., Kalurazi, T. Y., Pourkazemi, A., Vakilpour, A., Taramsari, M. R., & Ghorbani, Z. (2022). Green tea might be effective in alleviating COVID-19 associated psychiatric complications: Preliminary results from a pilot randomized controlled trial. Nutrition and Food Science, 52(4), 722-739."}, {"Citation": "Mahnashi, M. H., Alshahrani, M. A., Nahari, M. H., Hassan, S. S. U., Jan, M. S., Ayaz, M., Ullah, F., Alshehri, O. M., Alshehri, M. A., Rashid, U., & Sadiq, A. (2022). In-vitro, in-vivo, molecular docking and ADMET studies of 2-substituted 3, 7-dihydroxy-4H-chromen-4-one for oxidative stress, inflammation and Alzheimer's disease. Metabolites, 12(11), 1055."}, {"Citation": "Malekmohammad, K., & Rafieian-Kopaei, M. (2021). Mechanistic aspects of medicinal plants and secondary metabolites against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Current Pharmaceutical Design, 27(38), 3996-4007."}, {"Citation": "Malik, J. A., Ahmed, S., Shinde, M., Almermesh, M. H. S., Alghamdi, S., Hussain, A., & Anwar, S. (2022). The impact of COVID-19 on comorbidities: A review of recent updates for combating it. Saudi Journal of Biological Sciences, 29(5), 3586-3599."}, {"Citation": "Maurya, V. K., Kumar, S., Prasad, A. K., Bhatt, M. L., & Saxena, S. K. (2020). Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda againstSARS-CoV-2 spike glycoprotein and its cellular receptor. Virusdisease, 31, 179-193."}, {"Citation": "Mazza, C., Ricci, E., Biondi, S., Colasanti, M., Ferracuti, S., Napoli, C., & Roma, P. (2020). A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: Immediate psychological responses and associated factors. International Journal of Environmental Research and Public Health, 17(9), 3165."}, {"Citation": "McFadyen, J. D., Stevens, H., & Peter, K. (2020). The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications. Circulation Research, 127(4), 571-587."}, {"Citation": "Mei, J., Zhou, Y., Yang, X., Zhang, F., Liu, X., & Yu, B. (2021). Active components in Ephedra sinica stapf disrupt the interaction between ACE2 and SARS-CoV-2 RBD: Potent COVID-19 therapeutic agents. Journal of Ethnopharmacology, 278, 114303."}, {"Citation": "Meinhardt, J., Radke, J., Dittmayer, C., Franz, J., Thomas, C., Mothes, R., Laue, M., Schneider, J., Br\u00fcnink, S., Greuel, S., & Lehmann, M. (2021). Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nature neuroscience, 24(2), 168-175."}, {"Citation": "Menni, C., Valdes, A. M., Polidori, L., Antonelli, M., Penamakuri, S., Nogal, A., Louca, P., May, A., Figueiredo, J. C., & Hu, C. (2022). Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: A prospective observational study from the ZOE COVID study. The Lancet, 399(10335), 1618-1624."}, {"Citation": "Miryan, M., Bagherniya, M., Sahebkar, A., Soleimani, D., Rouhani, M. H., Iraj, B., & Askari, G. (2020). Effects of curcumin-piperine co-supplementation on clinical signs, duration, severity, and inflammatory factors in patients with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Trials, 21, 1-2."}, {"Citation": "M\u00f6nkem\u00fcller, K., Fry, L., & Rickes, S. (2020). COVID-19, coronavirus, SARS-CoV-2 and the small bowel. Revista Espa\u00f1ola de Enfermedades Digestivas, 112(5), 383-388."}, {"Citation": "Montealegre-G\u00f3mez, G., Garavito, E., G\u00f3mez-L\u00f3pez, A., Rojas-Villarraga, A., & Parra-Medina, R. (2021). Colchicine: A potential therapeutic tool against COVID-19. Experience of 5 patients. Reumatologia Clinica, 17(7), 371-375."}, {"Citation": "Moore, J. B., & June, C. H. (2020). Cytokine release syndrome in severe COVID-19. Science, 368(6490), 473-474."}, {"Citation": "Moschonas, I. C., & Tselepis, A. D. (2021). SARS-CoV-2 infection and thrombotic complications: A narrative review. Journal of Thrombosis and Thrombolysis, 52, 1-13."}, {"Citation": "Munaf\u00f2, F., Donati, E., Brindani, N., Ottonello, G., Armirotti, A., & De Vivo, M. (2022). Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Scientific Reports, 12(1), 1-9."}, {"Citation": "Murali, M., Nair, B., Vishnu, V. R., Aneesh, T. P., & Nath, L. R. (2022). 2, 4-Dihydroxycinnamic acid as spike ACE2 inhibitor and apigenin as RdRp inhibitor in Nimbamritadi Panchatiktam Kashayam against COVID-19: An in silico and in vitro approach. Molecular Diversity, 27, 1-11."}, {"Citation": "Nair, M. S., Huang, Y., Fidock, D. A., Polyak, S. J., Wagoner, J., Towler, M., & Weathers, P. (2021). Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants. Journal of Ethnopharmacology, 274, 114016."}, {"Citation": "Nair, M. S., Huang, Y., Fidock, D. A., Towler, M. J., & Weathers, P. J. (2022). Artemisia annua L. hot-water extracts show potent activity in vitro against Covid-19 variants including delta. Journal of Ethnopharmacology, 284, 114797."}, {"Citation": "Najjar, S., Najjar, A., Chong, D. J., Pramanik, B. K., Kirsch, C., Kuzniecky, R. I., Pacia, S. V., & Azhar, S. (2020). Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports. Journal of Neuroinflammation, 17(1), 1-14."}, {"Citation": "Nawrot-Hadzik, I., Zmudzinski, M., Matkowski, A., Preissner, R., K\u0119sik-Brodacka, M., Hadzik, J., Drag, M., & Abel, R. (2021). Reynoutria rhizomes as a natural source of SARS-CoV-2 Mpro inhibitors-molecular docking and in vitro study. Pharmaceuticals, 14(8), 742."}, {"Citation": "Nie, C., Trimpert, J., Moon, S., Haag, R., Gilmore, K., Kaufer, B. B., & Seeberger, P. H. (2021). In vitro efficacy of Artemisia extracts against SARS-CoV-2. Virology Journal, 18(1), 1-7."}, {"Citation": "Olajide, O. A., Iwuanyanwu, V. U., Lepiarz-Raba, I., Al-Hindawi, A. A., Aderogba, M. A., Sharp, H. L., & Nash, R. J. (2021). Garcinia kola and garcinoic acid suppress SARS-CoV-2 spike glycoprotein S1-induced hyper-inflammation in human PBMCs through inhibition of NF-kappa B activation. Phytotherapy Research, 35(12), 6963-6973."}, {"Citation": "Pachetti, M., Marini, B., Benedetti, F., Giudici, F., Mauro, E., Storici, P., Masciovecchio, C., Angeletti, S., Ciccozzi, M., & Gallo, R. C. (2020). Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA-polymerase variant. Journal of Translational Medicine, 18(1), 179."}, {"Citation": "Pal, P. B., Sinha, K., & Sil, P. C. (2014). Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNF\u03b1 related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats. PloS One, 9(9), e107220."}, {"Citation": "Panagiotopoulos, A. A., Karakasiliotis, I., Kotzampasi, D. M., Dimitriou, M., Sourvinos, G., Kampa, M., Pirintsos, S., Castanas, E., & Daskalakis, V. (2021). Natural polyphenols inhibit the dimerization of the SARS-CoV-2 main protease: The case of fortunellin and its structural analogs. Molecules, 26(19), 6068."}, {"Citation": "Perng, Y. C., & Lenschow, D. J. (2018). ISG15 in antiviral immunity and beyond. Nature Reviews Microbiology, 16(7), 423-439."}, {"Citation": "Perricone, C., Scarsi, M., Brucato, A., Pisano, P., Pigatto, E., Becattini, C., Cingolani, A., Tiso, F., Prota, R., & Tomasoni, L. R. (2023). Treatment with colchicine in hospitalized patients affected by COVID-19: The COLVID-19 trial. European Journal of Internal Medicine, 107, 30-36."}, {"Citation": "Plante, K. S., Dwivedi, V., Plante, J. A., Fernandez, D., Mirchandani, D., Bopp, N., Aguilar, P. V., Park, J.-G., Tamayo, P. P., & Delgado, J. (2021). (2021) \u2018antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2\u2019. Biomedicine and Pharmacotherapy, 138, 111457."}, {"Citation": "Pramanik, M. E. A., Miah, M. M. Z., Ahmed, I., Hossain, A. M., Ali, M. N., Haque, M. J., Islam, A. M., Jahan, R. A., Haque, M. E., & Rahman, M. M. (2022). Euphorbia neriifolia leaf juice on mild and moderate COVID-19 patients: Implications in OMICRON era. Euroasian Journal of Hepato-Gastroenterology, 12(1), 10-18."}, {"Citation": "Pung, R., Chiew, C. J., Young, B. E., Chin, S., Chen, M. I., Clapham, H. E., Cook, A. R., Maurer-Stroh, S., Toh, M. P., & Poh, C. (2020). Investigation of three clusters of COVID-19 in Singapore: Implications for surveillance and response measures. The Lancet, 395(10229), 1039-1046."}, {"Citation": "Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., & Wang, W. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases, 71(15), 762-768."}, {"Citation": "Qin, W., Ketnawa, S., & Ogawa, Y. (2022). Effect of digestive enzymes and pH on variation of bioavailability of green tea during simulated in vitro gastrointestinal digestion. Food Science and Human Wellness, 11(3), 669-675."}, {"Citation": "Raimi, I. O., Musyoki, A. M., Olatunji, O. A., Jimoh, M. O., Dube, W. V., & Olowoyo, J. O. (2022). Potential medicinal, nutritive and antiviral food plants: Africa's plausible answer to the low COVID-19 mortality. Journal of Herbmed Pharmacology, 11(1), 20-34."}, {"Citation": "Ratheesh, M., Sunil, S., Sheethal, S., Jose, S. P., Sandya, S., Ghosh, O. S. N., Rajan, S., Jagmag, T., & Tilwani, J. (2022). Anti-inflammatory and anti-COVID-19 effect of a novel polyherbal formulation (Imusil) via modulating oxidative stress, inflammatory mediators and cytokine storm. Inflammopharmacology, 30(1), 173-184."}, {"Citation": "Ren, J.-l., Zhang, A.-H., & Wang, X.-J. (2020). Traditional Chinese medicine for COVID-19 treatment. Pharmacological Research, 155, 104743."}, {"Citation": "Ribeiro, S. A., Lopes, C., Amaral, R., & Amaral, A. (2020). The therapeutic potential of colchicine in the complications of COVID19. Could the immunometabolic properties of an old and cheap drug help? Metabolism Open, 7, 100045."}, {"Citation": "Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M., Anto, J. M., Arcolaci, A., Azkur, A. K., & Azkur, D. (2020). A compendium answering 150 questions on COVID-19 and SARS-CoV-2. Allergy, 75(10), 2503-2541."}, {"Citation": "Roshdy, W. H., Rashed, H. A., Kandeil, A., Mostafa, A., Moatasim, Y., Kutkat, O., Abo Shama, N. M., Gomaa, M. R., El-Sayed, I. H., & El Guindy, N. M. (2020). EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One, 15(11), e0241739."}, {"Citation": "Saber-Moghaddam, N., Salari, S., Hejazi, S., Amini, M., Taherzadeh, Z., Eslami, S., Rezayat, S. M., Jaafari, M. R., & Elyasi, S. (2021). Oral nano-curcumin formulation efficacy in management of mild to moderate hospitalized coronavirus disease-19 patients: An open label nonrandomized clinical trial. Phytotherapy Research, 35(5), 2616-2623."}, {"Citation": "Sa-Ngiamsuntorn, K., Suksatu, A., Pewkliang, Y., Thongsri, P., Kanjanasirirat, P., Manopwisedjaroen, S., Charoensutthivarakul, S., Wongtrakoongate, P., Pitiporn, S., & Chaopreecha, J. (2021). Anti-SARS-CoV-2 activity of Andrographis paniculata extract and its major component Andrographolide in human lung epithelial cells and cytotoxicity evaluation in major organ cell representatives. Journal of Natural Products, 84(4), 1261-1270."}, {"Citation": "Sarkar, A., Paul, S., Singh, C., Chowdhury, N., Nag, P., Das, S., Kumar, S., Sharma, A., Das, D. K., Dutta, D., & Thakur, K. G. (2022). A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2. Virus Research, 315, 198768."}, {"Citation": "Sarkar, L., Oko, L., Gupta, S., Bubak, A. N., Das, B., Gupta, P., Safiriyu, A. A., Singhal, C., Neogi, U., Bloom, D., & Banerjee, A. (2022). Azadirachta indica A. Juss bark extract and its Nimbin isomers restrict \u03b2-coronaviral infection and replication. Virology, 569, 13-28."}, {"Citation": "Seo, S. H. (2022). Ginseng protects ACE2-transgenic mice from SARS-CoV-2 infection. Frontiers in Bioscience-Landmark, 27(6), 180."}, {"Citation": "Settanni, C. R., Ianiro, G., Ponziani, F. R., Bibb\u00f2, S., Segal, J. P., Cammarota, G., & Gasbarrini, A. (2021). COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms. World Journal of Gastroenterology, 27(43), 7433-7445."}, {"Citation": "Shah, A., Donovan, K., McHugh, A., Pandey, M., Aaron, L., Bradbury, C. A., Stanworth, S. J., Alikhan, R., Von Kier, S., & Maher, K. (2020). Thrombotic and haemorrhagic complications in critically ill patients with COVID-19: A multicentre observational study. Critical Care, 24(1), 1-10."}, {"Citation": "Shannon, A., Le, N. T.-T., Selisko, B., Eydoux, C., Alvarez, K., Guillemot, J.-C., Decroly, E., Peersen, O., Ferron, F., & Canard, B. (2020). Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 exonuclease active-sites. Antiviral Research, 178, 104793."}, {"Citation": "Sharma, V. K., Prateeksha, H., Singh, S. P., Singh, B. N., Rao, C. V., & Barik, S. K. (2022). Nanocurcumin potently inhibits SARS-CoV-2 spike protein-induced cytokine storm by deactivation of MAPK/NF-kappa B signaling in epithelial cells. Acs Applied Bio Materials, 5(2), 483-491."}, {"Citation": "Shi, C., Wu, M., Yang, K., & Wang, X. (2022). Lianhua Qingwen capsules reduced the rate of severity in patients with COVID-19: A system review and meta-analysis of randomized controlled trials. Evidence-Based Complementary and Alternative Medicine, 2022, 9617429."}, {"Citation": "Shi, T. H., Huang, Y. L., Chen, C. C., Pi, W. C., Hsu, Y. L., Lo, L. C., Chen, W. Y., Fu, S. L., & Lin, C. H. (2020). Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage. Biochemical and Biophysical Research Communications, 533(3), 467-473."}, {"Citation": "Shin, D., Mukherjee, R., Grewe, D., Bojkova, D., Baek, K., Bhattacharya, A., Schulz, L., Widera, M., Mehdipour, A. R., Tascher, G., & Geurink, P. P. (2020). Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity. Nature, 587(7835), 657-662."}, {"Citation": "Shiravi, A. A., Ardekani, A., Sheikhbahaei, E., & Heshmat-Ghahdarijani, K. (2022). Cardiovascular complications of SARS-CoV-2 vaccines: An overview. Cardiology and Therapy, 11, 13-21."}, {"Citation": "Siddiqi, H. K., & Mehra, M. R. (2020). COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. The Journal of Heart and Lung Transplantation, 39(5), 405-407."}, {"Citation": "Sokolowska, M., Lukasik, Z. M., Agache, I., Akdis, C. A., Akdis, D., Akdis, M., Barcik, W., Brough, H. A., Eiwegger, T., & Eljaszewicz, A. (2020). Immunology of COVID-19: Mechanisms, clinical outcome, diagnostics, and perspectives-A report of the European academy of allergy and clinical immunology (EAACI). Allergy, 75(10), 2445-2476."}, {"Citation": "Song, J., Zhang, L., Xu, Y., Yang, D., Yang, S., Zhang, W., Wang, J., Tian, S., Yang, S., & Yuan, T. (2021). The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro. Biochemical Pharmacology, 183, 114302."}, {"Citation": "Su, H. X., Yao, S., Zhao, W. F., Li, M. J., Liu, J., Shang, W. J., Xie, H., Ke, C. Q., Hu, H. C., Gao, M. N., Yu, K. Q., Liu, H., Shen, J. S., Tang, W., Zhang, L. K., Xiao, G. F., Ni, L., Wang, D. W., Zuo, J. P., \u2026 Xu, Y. C. (2020). Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients. Acta Pharmacologica Sinica, 41(9), 1167-1177."}, {"Citation": "Sun, Y., Wang, M., Lin, W., Dong, W., & Xu, J. (2023). Evolutionary analysis of omicron variant BF. 7 and BA. 5.2 pandemic in China. Journal of Biosafety and Biosecurity, 5(1), 14-20."}, {"Citation": "Suru\u010di\u0107, R., Travar, M., Petkovi\u0107, M., Tubi\u0107, B., Stojiljkovi\u0107, M. P., Grabe\u017e, M., \u0160avikin, K., Zduni\u0107, G., & \u0160krbi\u0107, R. (2021). Pomegranate peel extract polyphenols attenuate the SARS-CoV-2\u2009S-glycoprotein binding ability to ACE2 receptor: In silico and in vitro studies. Bioorganic Chemistry, 114, 105145."}, {"Citation": "Tahmasebi, S., El-Esawi, M. A., Mahmoud, Z. H., Timoshin, A., Valizadeh, H., Roshangar, L., Varshoch, M., Vaez, A., Aslani, S., & Navashenaq, J. G. (2021). Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients. Journal of Cellular Physiology, 236(7), 5325-5338."}, {"Citation": "Tang, W.-F., Tsai, H.-P., Chang, Y.-H., Chang, T.-Y., Hsieh, C.-F., Lin, C.-Y., Lin, G.-H., Chen, Y.-L., Jheng, J.-R., & Liu, P.-C. (2021). Perilla (Perilla frutescens) leaf extract inhibits SARS-CoV-2 via direct virus inactivation. Biomedical Journal, 44(3), 293-303."}, {"Citation": "Tanikawa, T., Hayashi, T., Suzuki, R., Kitamura, M., & Inoue, Y. (2022). Inhibitory effect of honokiol on furin-like activity and SARS-CoV-2 infection. Journal of Traditional and Complementary Medicine, 12(1), 69-72."}, {"Citation": "Tazeen, A., Deeba, F., Alam, A., Ali, R., Ishrat, R., Ahmed, A., Ali, S., & Parveen, S. (2021). Virtual screening of potential therapeutic inhibitors against spike, helicase, and polymerase of SARS-CoV-2 (COVID-19). Coronaviruses, 2(1), 89-105."}, {"Citation": "Tito, A., Colantuono, A., Pirone, L., Pedone, E., Intartaglia, D., Giamundo, G., Conte, I., Vitaglione, P., & Apone, F. (2021). Pomegranate peel extract as an inhibitor of SARS-CoV-2 spike binding to human ACE2 receptor (in vitro): A promising source of novel antiviral drugs. Frontiers in Chemistry, 9, 638187."}, {"Citation": "Tran, H. T. T., Gigl, M., Le, N. P. K., Dawid, C., & Lamy, E. (2021). In vitro effect of Taraxacum officinale leaf aqueous extract on the interaction between ACE2 cell surface receptor and SARS-CoV-2 spike protein D614 and four mutants. Pharmaceuticals, 14(10), 1055."}, {"Citation": "Upadhyay, S., Tripathi, P. K., Singh, M., Raghavendhar, S., Bhardwaj, M., & Patel, A. K. (2020). Evaluation of medicinal herbs as a potential therapeutic option against SARS-CoV-2 targeting its main protease. Phytotherapy Research, 34(12), 3411-3419."}, {"Citation": "Urda, L., Kreuter, M. H., Drewe, J., Boonen, G., Butterweck, V., & Klimkait, T. (2022). The Petasites hybridus CO2 extract (Ze 339) blocks SARS-CoV-2 replication in vitro. Viruses, 14(1), 106."}, {"Citation": "Vaarala, M. H., Porvari, K., Kyll\u00f6nen, A., Lukkarinen, O., & Vihko, P. (2001). The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: Detection of mutated TMPRSS2 form in a case of aggressive disease. International Journal of Cancer, 94(5), 705-710."}, {"Citation": "Valizadeh, H., Abdolmohammadi-Vahid, S., Danshina, S., Gencer, M. Z., Ammari, A., Sadeghi, A., Roshangar, L., Aslani, S., Esmaeilzadeh, A., & Ghaebi, M. (2020). Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients. International Immunopharmacology, 89, 107088."}, {"Citation": "van de Sand, L., Bormann, M., Alt, M., Schipper, L., Heilingloh, C. S., Steinmann, E., Todt, D., Dittmer, U., Elsner, C., & Witzke, O. (2021). Glycyrrhizin effectively inhibits SARS-CoV-2 replication by inhibiting the viral main protease. Viruses, 13(4), 609."}, {"Citation": "Varatharaj, A., Thomas, N., Ellul, M. A., Davies, N. W., Pollak, T. A., Tenorio, E. L., Sultan, M., Easton, A., Breen, G., & Zandi, M. (2020). Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. The Lancet Psychiatry, 7(10), 875-882."}, {"Citation": "V'kovski, P., Kratzel, A., Steiner, S., Stalder, H., & Thiel, V. (2021). Coronavirus biology and replication: Implications for SARS-CoV-2. Nature Reviews Microbiology, 19(3), 155-170."}, {"Citation": "Walsh, M. (2021). Effectiveness of Chinese herbal medicine and Persian medicine against viral infections: A systematic review. Systematic Reviews in Pharmacy, 12, 65-81."}, {"Citation": "Wan, Y., Shang, J., Graham, R., Baric, R. S., & Li, F. (2020). Receptor recognition by the novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS coronavirus. Journal of Virology, 94(7), e00127-20."}, {"Citation": "Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., & Xiong, Y. (2020). \u2018Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA, 323(11), 1061-1069."}, {"Citation": "Wang, W., Li, S. S., Xu, X. F., Yang, C., Niu, X. G., Yin, S. X., Pan, X. Y., Xu, W., Hu, G. D., Wang, C., & Liu, S. W. (2022). Danshensu alleviates pseudo-typed SARS-CoV-2 induced mouse acute lung inflammation. Acta Pharmacologica Sinica, 43(4), 771-780."}, {"Citation": "Wang, W. B., Li, Q. Q., Wu, J. J., Hu, Y., Wu, G., Yu, C. A. F., Xu, K. W., Liu, X. M., Wang, Q. H., Huang, W. J., Wang, L., & Wang, Y. C. (2021). Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants. Emerging Microbes and Infections, 10(1), 1519-1529."}, {"Citation": "Wang, X., Lin, S., Tang, R. W. L., Lee, H. C., Chan, H. H., Choi, S. S., Leung, K. W., Webb, S. E., Miller, A. L., & Tsim, K. W. K. (2022). Polygoni Multiflori radix extracts inhibit SARS-CoV-2 pseudovirus entry in HEK293T cells and zebrafish larvae. Phytomedicine, 102, 154154."}, {"Citation": "World Health Organization (2023). COVID-19 epidemiological update."}, {"Citation": "Wu, C., Zheng, M., Yang, Y., Gu, X., Yang, K., Li, M., Liu, Y., Zhang, Q., Zhang, P., & Wang, Y. (2020). Furin: A potential therapeutic target for COVID-19. Iscience, 23(10), 101642."}, {"Citation": "Wu, C.-Y., Lin, Y.-S., Yang, Y.-H., Shu, L.-H., Cheng, Y.-C., & Te Liu, H. (2020). GB-2 inhibits ACE2 and TMPRSS2 expression: In vivo and in vitro studies. Biomedicine and Pharmacotherapy, 132, 110816."}, {"Citation": "Wu, X., Dong, S., Chen, H., Guo, M., Sun, Z., & Luo, H. (2023). Perilla frutescens: A traditional medicine and food homologous plant. Chinese Herbal Medicines, 15(3), 369-375. https://doi.org/10.1016/j.chmed.2023.03.002"}, {"Citation": "Xiao, T., Wei, Y., Cui, M., Li, X., Ruan, H., Zhang, L., Bao, J., Ren, S., Gao, D., Wang, M., & Sun, R. (2021). Effect of dihydromyricetin on SARS-CoV-2 viral replication and pulmonary inflammation and fibrosis. Phytomedicine, 91, 153704."}, {"Citation": "Xiong, Y., Zhu, G.-H., Wang, H.-N., Hu, Q., Chen, L.-L., Guan, X.-Q., Li, H.-L., Chen, H.-Z., Tang, H., & Ge, G.-B. (2021). Discovery of naturally occurring inhibitors against SARS-CoV-2 3CLpro from Ginkgo biloba leaves via large-scale screening. Fitoterapia, 152, 104909."}, {"Citation": "Xiong, Y., Zhu, G.-H., Zhang, Y.-N., Hu, Q., Wang, H.-N., Yu, H.-N., Qin, X.-Y., Guan, X.-Q., Xiang, Y.-W., & Tang, H. (2021). Flavonoids in Ampelopsis grossedentata as covalent inhibitors of SARS-CoV-2 3CLpro: Inhibition potentials, covalent binding sites and inhibitory mechanisms. International Journal of Biological Macromolecules, 187, 976-987."}, {"Citation": "Yachou, Y., El Idrissi, A., Belapasov, V., & Ait Benali, S. (2020). Neuro invasion, neurotropic, and neuro inflammatory events of SARS-CoV-2: Understanding the neurological manifestations in COVID-19 patients. Neurological Sciences, 41, 2657-2669."}, {"Citation": "Yamabe, N., Yokozawa, T., Oya, T., & Kim, M. (2006). Therapeutic potential of (\u2212)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. Journal of Pharmacology and Experimental Therapeutics, 319(1), 228-236."}, {"Citation": "Yang, M., Lin, L., Scartelli, C., Chen, D.-Y., Patel, A., Bekendam, R., Sun, L., Saeed, M., & Flaumenhaft, R. (2021). Inhibition of Sars-Cov-2 viral replication and in Vivo thrombus formation by a novel plant flavonoid. Blood, 138, 3144."}, {"Citation": "Yang, X. L., Wang, C. X., Wang, J. X., Wu, S. M., Yong, Q., Li, K., & Yang, J. R. (2023). In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury. Frontiers in Pharmacology, 14, 1188086."}, {"Citation": "Yang, Y., Islam, M. S., Wang, J., Li, Y., & Chen, X. (2020). Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2): A review and perspective. International Journal of Biological Sciences, 16(10), 1708-1717."}, {"Citation": "Yepes-Perez, A. F., Herrera-Calder\u00f3n, O., Oliveros, C. A., Fl\u00f3rez-\u00c1lvarez, L., Zapata-Cardona, M. I., Yepes, L., Aguilar-Jimenez, W., Rugeles, M. T., & Zapata, W. (2021). The Hydroalcoholic extract of Uncaria tomentosa (Cat's claw) inhibits the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro. Evidence-Based Complementary and Alternative Medicine, 2021, 1-11."}, {"Citation": "Yingwen, Z. (2021). Chinese, European and Persian medicine recommendations for the prevention of pandemics (COVID-19) related to the respiratory system: A systematic review. Systematic Reviews in Pharmacy, 12(2), 10-23."}, {"Citation": "Yu, S. P., Chen, Y., Xiang, Y. S., Lin, H., Wang, M. G., Ye, W. B., Zhang, P., Chen, H. Z., Lin, G. Q., Zhu, Y. Y., Chen, L. L., & Zhang, J. G. (2021). Pseudoephedrine and its derivatives antagonize wild and mutated severe acute respiratory syndrome-CoV-2 viruses through blocking virus invasion and antiinflammatory effect. Phytotherapy Research, 35(10), 5847-5860."}, {"Citation": "Yuan, S., Gao, X., Tang, K., Cai, J. P., Hu, M., Luo, P., Wen, L., Ye, Z. W., Luo, C., Tsang, J. O. L., & Chan, C. C. Y. (2022). Targeting papain-like protease for broad-spectrum coronavirus inhibition. Protein and Cell, 13(12), 940-953."}, {"Citation": "Zandi, K., Musall, K., Oo, A., Cao, D., Liang, B., Hassandarvish, P., Lan, S., Slack, R. L., Kirby, K. A., Bassit, L., & Amblard, F. (2021). Baicalein and baicalin inhibit SARS-CoV-2 RNA-dependent-RNA polymerase. Microorganisms, 9(5), 893."}, {"Citation": "Zaragoza-Huesca, D., Mart\u00ednez-Cort\u00e9s, C., Banegas-Luna, A. J., P\u00e9rez-Garrido, A., Vegara-Meseguer, J. M., Pe\u00f1as-Mart\u00ednez, J., Rodenas, M. C., Esp\u00edn, S., P\u00e9rez-S\u00e1nchez, H., & Mart\u00ednez-Mart\u00ednez, I. (2022). Identification of kukoamine A, zeaxanthin, and clexane as new furin inhibitors. International Journal of Molecular Sciences, 23(5), 2796."}, {"Citation": "Zekeya, N., Mamiro, B., Ndossi, H., Mallya, R. C., Kilonzo, M., Kisingo, A., Mtambo, M., Kideghesho, J., & Chilongola, J. (2022). Screening and evaluation of cytotoxicity and antiviral effects of secondary metabolites from water extracts of Bersama abyssinica against SARS-CoV-2 Delta. BMC Complementary Medicine and Therapies, 22(1), 280."}, {"Citation": "Zhan, Y., Ta, W., Tang, W., Hua, R., Wang, J., Wang, C., & Lu, W. (2021). Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro. Drug Development Research, 82(8), 1124-1130."}, {"Citation": "Zhang, J., & Li, M. (2023). A focus on harnessing big data and artificial intelligence: revolutionizing drug discovery from traditional Chinese medicine sources, Chemical Science, 39, 10628-10630. https://doi.org/10.1039/D3SC90185H"}, {"Citation": "Zhang, C., Shi, L., & Wang, F.-S. (2020). Liver injury in COVID-19: Management and challenges. The Lancet Gastroenterology & Hepatology, 5(5), 428-430."}, {"Citation": "Zhang, J. j., Cao, Y. Y., Tan, G., Dong, X., Wang, B. C., Lin, J., Yan, Y. Q., Liu, G. H., Akdis, M., & Akdis, C. A. (2021). Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients. Allergy, 76(2), 533-550."}, {"Citation": "Zhang, Y., Pang, Y., Xu, B., Chen, X., Liang, S., Hu, J., & Luo, X. (2022). Folic acid restricts SARS-CoV-2 invasion by methylating ACE2. Frontiers in Microbiology, 13, 980903."}, {"Citation": "Zhao, Z., Xiao, Y., Xu, L., Liu, Y., Jiang, G., Wang, W., Li, B., Zhu, T., Tan, Q., & Tang, L. (2021). Glycyrrhizic acid nanoparticles as antiviral and anti-inflammatory agents for COVID-19 treatment. ACS Applied Materials & Interfaces, 13(18), 20995-21006."}, {"Citation": "Zheng, B., Zhang, Q., Geng, G., Chen, C., Shi, Q., Cui, M., Lei, Y., & He, K. (2021). Changes in China's anthropogenic emissions and air quality during the COVID-19 pandemic in 2020. Earth System Science Data, 13(6), 2895-2907."}, {"Citation": "Zhou, G., & Wang, G. (2020). Inhibitory drugs for the COVID-19 receptor ACE2 and their applications. Cancer Hospital of the Chinese Academy of Medical Sciences Patent CN112057488B. Available at: https://d.wanfangdata.com.cn/patent/ChJQYXRlbnROZXdTMjAyMzA5MDESE0NOMjAyMDExMjQ5ODE5LjNfc3EaCGtydG1vcHE3 [Accessed: 26th September 2023]"}, {"Citation": "Zhou, Y., Gilmore, K., Ramirez, S., Settels, E., Gammeltoft, K. A., Pham, L. V., Fahn\u00f8e, U., Feng, S., Offersgaard, A., & Trimpert, J. (2021). In vitro efficacy of artemisinin-based treatments against SARS-CoV-2. Scientific Reports, 11(1), 1-14."}, {"Citation": "Zhu, Y., & Xie, D.-Y. (2020). Docking characterization and in vitro inhibitory activity of flavan-3-ols and dimeric proanthocyanidins against the main protease activity of SARS-Cov-2. Frontiers in Plant Science, 11, 1884."}], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "12", "Day": "13"}, {"Year": "2023", "Month": "8", "Day": "9"}, {"Year": "2023", "Month": "12", "Day": "15"}, {"Year": "2024", "Month": "3", "Day": "14", "Hour": "6", "Minute": "46"}, {"Year": "2024", "Month": "1", "Day": "29", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "28", "Hour": "19", "Minute": "42"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38281731", "10.1002/ptr.8105"]}}]}